293 related articles for article (PubMed ID: 23604115)
1. Targeting homologous recombination and telomerase in Barrett's adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growth.
Lu R; Pal J; Buon L; Nanjappa P; Shi J; Fulciniti M; Tai YT; Guo L; Yu M; Gryaznov S; Munshi NC; Shammas MA
Oncogene; 2014 Mar; 33(12):1495-505. PubMed ID: 23604115
[TBL] [Abstract][Full Text] [Related]
2. Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor.
Shammas MA; Koley H; Beer DG; Li C; Goyal RK; Munshi NC
Gastroenterology; 2004 May; 126(5):1337-46. PubMed ID: 15131795
[TBL] [Abstract][Full Text] [Related]
3. Biology of telomeres: importance in etiology of esophageal cancer and as therapeutic target.
Pal J; Gold JS; Munshi NC; Shammas MA
Transl Res; 2013 Dec; 162(6):364-70. PubMed ID: 24090770
[TBL] [Abstract][Full Text] [Related]
4. Genomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome.
Pal J; Bertheau R; Buon L; Qazi A; Batchu RB; Bandyopadhyay S; Ali-Fehmi R; Beer DG; Weaver DW; Shmookler Reis RJ; Goyal RK; Huang Q; Munshi NC; Shammas MA
Oncogene; 2011 Aug; 30(33):3585-98. PubMed ID: 21423218
[TBL] [Abstract][Full Text] [Related]
5. Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo.
Shammas MA; Qazi A; Batchu RB; Bertheau RC; Wong JY; Rao MY; Prasad M; Chanda D; Ponnazhagan S; Anderson KC; Steffes CP; Munshi NC; De Vivo I; Beer DG; Gryaznov S; Weaver DW; Goyal RK
Clin Cancer Res; 2008 Aug; 14(15):4971-80. PubMed ID: 18676772
[TBL] [Abstract][Full Text] [Related]
6. Alternative lengthening of telomeres is induced by telomerase inhibitors in Barrett's esophageal cells.
Qin X; Qi B; Zhao B
Oncol Rep; 2013 Apr; 29(4):1399-404. PubMed ID: 23338150
[TBL] [Abstract][Full Text] [Related]
7. Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential.
Shammas MA; Koley H; Batchu RB; Bertheau RC; Protopopov A; Munshi NC; Goyal RK
Mol Cancer; 2005 Jul; 4():24. PubMed ID: 16022731
[TBL] [Abstract][Full Text] [Related]
8. Impact of RAD51C-mediated Homologous Recombination on Genomic Integrity in Barrett's Adenocarcinoma Cells.
Pal J; Nanjappa P; Kumar S; Shi J; Buon L; Munshi NC; Shammas MA
J Gastroenterol Hepatol Res; 2017; 6(1):2286-2295. PubMed ID: 29399538
[TBL] [Abstract][Full Text] [Related]
9. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.
Lord RV; Salonga D; Danenberg KD; Peters JH; DeMeester TR; Park JM; Johansson J; Skinner KA; Chandrasoma P; DeMeester SR; Bremner CG; Tsai PI; Danenberg PV
J Gastrointest Surg; 2000; 4(2):135-42. PubMed ID: 10675236
[TBL] [Abstract][Full Text] [Related]
10. Targeting PI3K and RAD51 in Barrett's adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growth.
Pal J; Fulciniti M; Nanjappa P; Buon L; Tai YT; Tassone P; Munshi NC; Shammas MA
Cancer Genomics Proteomics; 2012; 9(2):55-66. PubMed ID: 22399496
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death.
Liu R; Liu J; Wang S; Wang Y; Zhang T; Liu Y; Geng X; Wang F
Cell Death Dis; 2019 Jul; 10(7):527. PubMed ID: 31296842
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal instability in Barrett's esophagus is related to telomere shortening.
Finley JC; Reid BJ; Odze RD; Sanchez CA; Galipeau P; Li X; Self SG; Gollahon KA; Blount PL; Rabinovitch PS
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1451-7. PubMed ID: 16896031
[TBL] [Abstract][Full Text] [Related]
13. RAD51 and RTEL1 compensate telomere loss in the absence of telomerase.
Olivier M; Charbonnel C; Amiard S; White CI; Gallego ME
Nucleic Acids Res; 2018 Mar; 46(5):2432-2445. PubMed ID: 29346668
[TBL] [Abstract][Full Text] [Related]
14. Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
Frink RE; Peyton M; Schiller JH; Gazdar AF; Shay JW; Minna JD
Oncotarget; 2016 May; 7(22):31639-51. PubMed ID: 27192120
[TBL] [Abstract][Full Text] [Related]
15. Influence of genetics on tumoral pathologies: the example of the adenocarcinoma arising in Barrett's esophagus.
Villanacci V; Bassotti G; Salemme M; Rossi E
Rev Esp Enferm Dig; 2012 Dec; 104(11):592-602. PubMed ID: 23368651
[TBL] [Abstract][Full Text] [Related]
16. Telomere shortening in Barrett's mucosa and esophageal adenocarcinoma and its association with loss of heterozygosity.
Shiraishi H; Mikami T; Aida J; Nakamura K; Izumiyama-Shimomura N; Arai T; Watanabe M; Okayasu I; Takubo K
Scand J Gastroenterol; 2009; 44(5):538-44. PubMed ID: 19221928
[TBL] [Abstract][Full Text] [Related]
17. Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells.
Barszczyk M; Buczkowicz P; Castelo-Branco P; Mack SC; Ramaswamy V; Mangerel J; Agnihotri S; Remke M; Golbourn B; Pajovic S; Elizabeth C; Yu M; Luu B; Morrison A; Adamski J; Nethery-Brokx K; Li XN; Van Meter T; Dirks PB; Rutka JT; Taylor MD; Tabori U; Hawkins C
Acta Neuropathol; 2014 Dec; 128(6):863-77. PubMed ID: 25120190
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
[TBL] [Abstract][Full Text] [Related]
19. Anticancer therapy targeting telomeres and telomerase : current status.
Parkinson EK; Minty F
BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
